SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Bob who wrote (1676)10/19/1998 11:11:00 PM
From: Marshall Teitelbaum  Read Replies (1) of 2205
 
Bob,

I'm not sure I would say better investment, but I would say that there is far more potential for ATIS as the consummate tissue engineering company. Nevertheless, LIFC is making good progress and is lesser traded company with less needed to move forward stockprice-wise. Thrombosol has gotten good reviews lately, too, although I see the products ATIS working on as having potentially far larger markets, but potential is like a blind date.....don't know until.... My belief is that the fundamentals are in place for ATIS, making it hard for others in the industry to keep up IF they come through in the majority of research areas over the next 5-10 years.

Just a general quickie, but time spent on the computer is reduced these days. Your input as to LIFC would be interesting to hear. Discussion over here has been lacking for some time, and I haven't followed LIFC as closely the last few months as I used to.

Regards,

Marshall
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News